Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC).
Pharmazie
; 72(10): 568-570, 2017 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-29441879
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Doxorubicin
/
Chromatography, High Pressure Liquid
/
Cyclooxygenase 2 Inhibitors
/
Celecoxib
/
Antibiotics, Antineoplastic
Language:
En
Journal:
Pharmazie
Journal subject:
FARMACIA
Year:
2017
Document type:
Article
Country of publication: